The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Comparison of Methods for Delivering a Lifestyle Modification Program for Obese Patients: A Randomized Trial
Abstract
BACKGROUND: Physicians frequently prescribe medications for weight loss but offer minimal lifestyle counseling despite the additional benefits of combining both interventions. OBJECTIVE: To compare 5 methods of delivering a lifestyle modification program to obese patients receiving sibutramine. DESIGN: Randomized, 6-month, open-label study. Participants were assigned to intervention groups by using a computer-generated schedule of randomly permuted blocks. Block length was 5. SETTING: 12 independent research clinics with experience running obesity trials. PATIENTS: 376 patients with obesity (body mass index > or =30 and <40 kg/m(2)). INTERVENTION: High-frequency face-to-face lifestyle modification counseling (HF-F2F) (n = 74), low-frequency face-to-face counseling (LF-F2F) (n = 76), high-frequency telephone counseling (HF-TEL) (n = 76), high-frequency e-mail counseling (HF-EMAIL) (n = 74), or no dietitian contact (self-help [SELF]) (n = 76). All participants received sibutramine, 10 mg/d; a lifestyle manual; and access to a weight-loss Web site. MEASUREMENTS: Percentage change in body weight at 6 months was the primary outcome. Secondary end points included changes in waist circumference; lipid, glucose, and insulin levels; blood pressure; weight-related symptoms; and quality of life at 6 months. RESULTS: At 6 months, the mean weight loss, relative to baseline, in the HF-F2F and HF-TEL groups was similar (8.9% [95% CI, 8.0% to 9.8%] and 7.7% [CI, 6.8% to 8.7%]) and significantly greater than that in the other groups (LF-F2F, 6.4% [CI, 5.4% to 7.3%]; HF-EMAIL, 5.9% [CI, 5.0% to 6.8%]; and SELF, 5.2% [CI, 4.3% to 6.1%]). All groups showed significant improvements in waist circumference, high-density lipoprotein cholesterol and triglyceride levels, and measures of quality of life and weight-related symptoms. There were no serious adverse events and no differences in minor events among groups. LIMITATION: Most participants were women, and the attrition rate was 30%. CONCLUSION: High-frequency telephone contact with a dietitian was similar to HF-F2F contact for supporting lifestyle modification in obese patients trying to lose weight. The findings might be used by providers and health systems to promote healthy lifestyle changes for their patients. FUNDING: Pfizer Global Research and Development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,453
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
The Disease Burden Associated With Overweight and Obesity
Must, A. (1999) · JAMA · doi:10.1001/jama.282.16.1523 · Cited by 4,827
Pi-Sunyer, X., Aronne, L. J., Heshmati, H. M., Devin, J., Rosenstock, J., & for the RIO-North America Study Group (2006) · JAMA · doi:10.1001/jama.295.7.761 · Cited by 1,227
Using Internet technology to deliver a behavioral weight loss program
Tate, D. F. (2001) · JAMA · doi:10.1001/jama.285.9.1172 · Cited by 925 · cited 1×
“Mean diastolic blood pressure (SD), mm Hg 79 (6) 79 (7) 79 (6) 78 (7) 79 (6)”
Long term pharmacotherapy for obesity and overweight: updated meta-analysis
Rucker, D., Padwal, R., Li, S. K., Curioni, C., & Lau, D. C. W. (2007) · BMJ · doi:10.1136/bmj.39385.413113.25 · Cited by 801
Randomized Trial of Lifestyle Modification and Pharmacotherapy for Obesity
Wadden, T. A., Berkowitz, R. I., Womble, L. G., Sarwer, D. B., Phelan, S., Cato, R. K., Hesson, L. A., Osei, S. Y., Kaplan, R., & Stunkard, A. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050156 · Cited by 794
Tate, D. F., Jackvony, E. H., & Wing, R. R. (2003) · JAMA · doi:10.1001/jama.289.14.1833 · Cited by 666
Development of a brief measure to assess quality of life in obesity
Kolotkin, R. L., Crosby, R. D., Kosloski, K. D., & Williams, G. R. (2001) · Obesity Research · doi:10.1038/oby.2001.13 · Cited by 641
Research works printed but not linked: 1
- 1998, Obes Res, 6, 51S
Cited by
Sorted by citations
Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice
Appel, L. J., Clark, J. M., Yeh, H.-C., Wang, N.-Y., Coughlin, J. W., Daumit, G., Miller, E. R., Dalcin, A., Jerome, G. J., Geller, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108660 · Cited by 783
Behavioral treatment of obesity
Butryn, M. L., Webb, V., & Wadden, T. A. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.08.006 · Cited by 636
Wadden, T. A., Foreyt, J. P., Foster, G. D., Hill, J. O., Klein, S., O'Neil, P. M., Perri, M. G., Pi‐Sunyer, F. X., Rock, C. L., Erickson, J. S., et al. (2011) · Obesity · doi:10.1038/oby.2010.147 · Cited by 558
A Two-Year Randomized Trial of Obesity Treatment in Primary Care Practice
Wadden, T. A., Volger, S., Sarwer, D. B., Vetter, M. L., Tsai, A. G., Berkowitz, R. I., Kumanyika, S., Schmitz, K. H., Diewald, L. K., Barg, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109220 · Cited by 487
Bazzano, L. A., Thompson, A. M., Tees, M. T., Nguyen, C. H., & Winham, D. M. (2011) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.08.012 · Cited by 300
Treatment of childhood obesity by retraining eating behaviour: Randomised controlled trial
Ford, A. L., Bergh, C., Sodersten, P., Sabin, M. A., Hollinghurst, S., Hunt, L. P., & Shield, J. P. H. (2009) · BMJ · doi:10.1136/bmj.b5388 · Cited by 214
Wadden, T. A., Tronieri, J. S., Sugimoto, D., Lund, M. T., Auerbach, P., Jensen, C., & Rubino, D. (2020) · Obesity · doi:10.1002/oby.22726 · Cited by 200
Desroches, S., Lapointe, A., Ratté, S., Gravel, K., Légaré, F., & Turcotte, S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008722.pub2 · Cited by 187
Behavior therapy for obesity: where are we now?
Sarwer, D. B., von Sydow Green, A., Vetter, M. L., & Wadden, T. A. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32832f5a79 · Cited by 120
Internet-Based Behavioral Interventions for Obesity: An Updated Systematic Review
Manzoni, G. M., Pagnini, F., Corti, S., Molinari, E., & Castelnuovo, G. (2011) · Clinical Practice & Epidemiology in Mental Health · doi:10.2174/1745017901107010019 · Cited by 119
Temmingh, H., Claassen, A., van Zyl, S., Carrara, H., Dayakalashe, N. M., Myer, L., & Stein, D. J. (2013) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000036 · Cited by 31
Gallagher, C., Corl, A., & Dietz, W. H. (2021) · Obesity · doi:10.1002/oby.23154 · Cited by 32
Metadata
- Authors
- Digenio, A. G., Mancuso, J. P., Gerber, R. A., & Dvorak, R. V.
- Affiliations
- Pfizer (United States) (US)
- Corresponding author
- Digenio, Andres G.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2009-02-17
- Volume
- 150
- Issue
- 4
- Pages
- 255-262
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1973362692
- Cited by
- 148
- References
- 16
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 9 · 2020: 6 · 2019: 10 · 2018: 3 · 2017: 9 · 2016: 10 · 2015: 4 · 2014: 15 · 2013: 16 · 2012: 16
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- obesity, lifestyle modification, sibutramine, telephone counseling, email counseling, face-to-face counseling, weight loss, telephone-delivered intervention, self-help, waist circumference, serum lipids, quality of life, pharmacist counseling, attrition, obese women, blood pressure
- MeSH terms
- Adult, Appetite Depressants, Behavior Therapy, Combined Modality Therapy, Counseling, Cyclobutanes, Female, Humans, Life Style, Male, Middle Aged, Obesity, Patient Compliance, Patient Dropouts, Weight Loss, Treatment Outcome, Waist Circumference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review